- Vivera Pharmaceuticals and Burkhan World recently announced $440 million in financial backing by JR Dallas Wealth Management in support of Vivera’s global growth strategies
Vivera Pharmaceuticals and Burkhan World recently announced $440 million in financial backing by JR Dallas Wealth Management in support of Vivera’s global growth strategies. And this ongoing partnership will provide financial services – including debt and equity backing – for the purchase and distribution of Vivera’s innovative testing and expansive medical supply offerings.
JR Dallas Wealth Management is known as a boutique private equity investment firm with over 30 years of private and public equity experience with a proven track record of success. And by providing financial support, JR Dallas Wealth Management’s ongoing involvement will be key in establishing a United States supply chain for testing, masks, gloves, and gowns – items that are globally in short supply as the pandemic continues.
Burkhan World has partnered with Vivera to expand the company’s PPE offerings. And with management expertise in hospitality and finance, the Burkhan World Group of Companies — which is based in Washington D.C. — is a global investor and partner focused on projects that have a positive impact on society.
Vivera Pharmaceuticals and the Burkhan World Group of Companies are working together to expand access by connecting key suppliers and resources to Vivera’s expansive network of hospitals, specialty care facilities, and medical distributors.
KEY QUOTES:
“We have seen how important a stable domestic supply chain is over the last few months. Reliable testing and certified personal protective equipment manufactured in the United States plays a key role in the pandemic response and getting our communities back to work. We welcome the expertise of both Burkhan World and JR Dallas Wealth Management as we address the ongoing demand for trusted testing and medical supplies.”
— Paul Edalat, CEO of Vivera Pharmaceuticals
“We firmly believe in investing in and backing those enterprises doing a great job at being socially responsible. Our new partner, Vivera Pharmaceuticals, is the ideal strategic partner for our vision to make a difference in peoples’ lives.”
— Jehangir A. Raja, CEO of JR Dallas Wealth Management
“Burkhan is honoured to have partnered up with Vivera in supporting its efforts globally in the medical supply sector. As partners with Vivera and JR Dallas Wealth Management, we look forward to facilitating re-opening our communities and getting essential supplies into the hands of those most in need.”
— Shafi Khan, Burkhan World’s VP of Business Development
